Lieff Cabraser Reminds AmTrust Financial Services, Inc. Investors Of Upcoming Deadline In Class Action Litigation – AFSI
Lieff, Cabraser, Heimann & Bernstein, LLP reminds investors of the April
7, 2014 deadline to move for appointment as lead plaintiff in the
class litigation brought on behalf of purchasers of the securities of...
Lieff, Cabraser, Heimann & Bernstein, LLP reminds investors of the April 7, 2014 deadline to move for appointment as lead plaintiff in the securities class litigation brought on behalf of purchasers of the securities of AmTrust Financial Services, Inc. (“AmTrust” or the “Company”) (NasdaqGS: AFSI) between February 15, 2011 and December 11, 2013, inclusive (the “Class Period”). If you purchased the securities of AmTrust during the Class Period, you may move the Court for appointment as lead plaintiff by no later than April 7, 2014. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. Your share of any recovery in the action will not be affected by your decision of whether to seek appointment as lead plaintiff. You may retain Lieff Cabraser, or other attorneys, as your counsel in the action. AmTrust investors who wish to learn more about the action and how to seek appointment as lead plaintiff should click here or contact Sharon M. Lee of Lieff Cabraser toll-free at 1-800-541-7358. AmTrust, headquartered in New York, New York, offers insurance coverage to policyholders including property/casualty, workers’ compensation, special risk, and warranty insurance, and extended service plans. The action alleges that defendants made false and/or misleading statements throughout the Class Period, as well as failed to disclose material adverse information, about AmTrust’s business, operations, and prospects, in violation of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. On December 12, 2013, a report by analyst firm GeoInvesting exposed certain alleged accounting improprieties at AmTrust. Such alleged improprieties included: 1) manipulation of AmTrust’s loan loss reserves, thereby inflating reported earnings; 2) manipulation of the Company’s deferred tax liabilities; and 3) underestimation of the Company’s discount rates for its life settlement contracts in order to inflate AmTrust’s reported assets and total stockholder’s equity.